Elke Scandella
- Immunology top 0.5%
- Immunotherapy and Immune Responses 17
- T-cell and B-cell Immunology 14
- Immune Cell Function and Interaction 13
- IL-33, ST2, and ILC Pathways 5
- Immune Response and Inflammation 4
- Oncology top 5%
- Lymphatic System and Diseases 4
- Chemokine receptors and signaling 4
- Immunology and Allergy top 5%
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research 3
- Virology top 10%
- Co-authors
- Burkhard LudewigMarcus GroettrupYing MenSilke GillessenTobias JuntReinhold FörsterLucas OnderDaniel F. Legler
- Journals
- Journal of Biological Chemistry (2 papers)Nature Communications (3 papers)The Journal of Experimental Medicine (1 paper)
- Partner nations
- SwitzerlandGermanyAustria
In The Last Decade
Elke Scandella
52 papers receiving 3.5k citations
Peers
Comparison fields: 5 of 121
- Immunology 2.5k
- Oncology 798
- Immunology and Allergy 151
- Infectious Diseases 271
- Virology 66
Countries citing papers authored by Elke Scandella
This map shows the geographic impact of Elke Scandella's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elke Scandella with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elke Scandella more than expected).
Fields of papers citing papers by Elke Scandella
This network shows the impact of papers produced by Elke Scandella. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elke Scandella. The network helps show where Elke Scandella may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Elke Scandella, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 14 | |
| 2 | 2021 | 21 | |
| 3 | 2021 | 36 | |
| 4 | 2019 | 73 | |
| 5 | 2018 | 43 | |
| 6 | 2016 | 68 | |
| 7 | 2016 | 46 | |
| 8 | 2012 | 3 | |
| 9 | 2012 | 14 | |
| 10 | 2008 | 103 | |
| 11 | 2008 | 210 | |
| 12 | 2007 | 39 | |
| 13 | 2006 | 181 | |
| 14 | 2006 | 3 | |
| 15 | 2006 | 11 | |
| 16 | 2005 | 51 | |
| 17 | 2005 | 9 | |
| 18 | 2005 | 9 | |
| 19 | 2004 | 7 | |
| 20 | 2004 | 73 |
About Elke Scandella
Elke Scandella is a scholar working on Immunology, Aging and Oncology, having authored 53 papers that have together received 3.6k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (17 papers), T-cell and B-cell Immunology (14 papers), Immune Cell Function and Interaction (13 papers), IL-33, ST2, and ILC Pathways (5 papers), Lymphatic System and Diseases (4 papers), Chemokine receptors and signaling (4 papers), Immune Response and Inflammation (4 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). The work is most often cited by research in Immunology (2.5k citations), Oncology (798 citations) and Immunology and Allergy (151 citations). Elke Scandella has collaborated with scholars based in Switzerland, Germany and Austria. Frequent co-authors include Burkhard Ludewig, Marcus Groettrup, Ying Men, Silke Gillessen, Tobias Junt, Reinhold Förster, Lucas Onder, Daniel F. Legler, Qian Chai and Jens V. Stein. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications and The Journal of Experimental Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.